ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

O’Leary Leads RPCI’s OR;

February 8, 2002

In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay

June 3, 1977

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009